Skip to main content
Equibles

Pier Capital, LLC

Position in CYTK — Cytokinetics Inc

CIK 1310051 STAMFORD, CT
Back to CYTK Full portfolio

Position in CYTK

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$6,019,951
+$1,433,736 QoQ
Shares Held
70,665
+1.6% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 62% Shared 0% None 38%

Common Shares in CYTK Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Pier Capital, LLC holds $37,295,784 across 8 Biotechnology names. CYTK ranks #3 (16.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DRTS
Alpha Tau Medical Ltd.
 691,939 $8,704,592
2 COGT
Cogent Biosciences, Inc.
 188,951 $7,312,403
3 CYTK
Cytokinetics Inc
This page 		70,665 $6,019,951
4 DFTX
Definium Therapeutics, Inc.
 88,598 $4,167,649
5 SPTX
Seaport Therapeutics, Inc.
 169,985 $3,692,074
6 OLMA
Olema Pharmaceuticals, Inc.
 220,699 $2,760,944
7 CAPR
Capricor Therapeutics, Inc.
 111,908 $2,694,744
8 KYMR
Kymera Therapeutics, Inc.
 16,948 $1,943,427

All Filings in CYTK

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,019,951 70,665
2026-03-31 $4,586,215 69,583